These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 30712764)
21. Antimicrobial resistance among Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors. Bonelli RR; Moreira BM; Picão RC Drug Resist Updat; 2014 Apr; 17(1-2):24-36. PubMed ID: 24618111 [TBL] [Abstract][Full Text] [Related]
22. Travel and the Spread of Drug-Resistant Bacteria. Schwartz KL; Morris SK Curr Infect Dis Rep; 2018 Jun; 20(9):29. PubMed ID: 29959541 [TBL] [Abstract][Full Text] [Related]
23. Increasing Globalization and the Movement of Antimicrobial Resistance between Countries. Berndtson AE Surg Infect (Larchmt); 2020 Sep; 21(7):579-585. PubMed ID: 32434446 [No Abstract] [Full Text] [Related]
24. Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India. Bharadwaj R; Robinson ML; Balasubramanian U; Kulkarni V; Kagal A; Raichur P; Khadse S; Kadam D; Valvi C; Kinikar A; Kanade S; Suryavanshi N; Marbaniang I; Nelson G; Johnson J; Zenilman J; Sachs J; Gupta A; Mave V BMC Infect Dis; 2018 Oct; 18(1):504. PubMed ID: 30286741 [TBL] [Abstract][Full Text] [Related]
25. Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Rodríguez-Baño J; Cisneros JM; Cobos-Trigueros N; Fresco G; Navarro-San Francisco C; Gudiol C; Horcajada JP; López-Cerero L; Martínez JA; Molina J; Montero M; Paño-Pardo JR; Pascual A; Peña C; Pintado V; Retamar P; Tomás M; Borges-Sa M; Garnacho-Montero J; Bou G; Enferm Infecc Microbiol Clin; 2015 May; 33(5):338-41. PubMed ID: 25563393 [TBL] [Abstract][Full Text] [Related]
26. The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan. Blakiston M; Heffernan H; Roberts S; Freeman J N Z Med J; 2017 Apr; 130(1454):72-79. PubMed ID: 28449019 [TBL] [Abstract][Full Text] [Related]
27. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Grundmann H; Livermore DM; Giske CG; Canton R; Rossolini GM; Campos J; Vatopoulos A; Gniadkowski M; Toth A; Pfeifer Y; Jarlier V; Carmeli Y; Euro Surveill; 2010 Nov; 15(46):. PubMed ID: 21144429 [TBL] [Abstract][Full Text] [Related]
28. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years. Aris P; Boroumand MA; Rahbar M; Douraghi M Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348 [TBL] [Abstract][Full Text] [Related]
29. Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae. Mathers A Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337454 [TBL] [Abstract][Full Text] [Related]
30. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era? Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045 [TBL] [Abstract][Full Text] [Related]
31. Hong Kong experiences the 'Ultimate superbug': NDM-1 Enterobacteriaceae. Tsang KY; Luk S; Lo JY; Tsang TY; Lai ST; Ng TK Hong Kong Med J; 2012 Oct; 18(5):439-41. PubMed ID: 23018074 [TBL] [Abstract][Full Text] [Related]
32. Treatment of Infections by OXA-48-Producing Enterobacteriaceae. Stewart A; Harris P; Henderson A; Paterson D Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104282 [TBL] [Abstract][Full Text] [Related]
33. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy? Perez F; El Chakhtoura NG; Papp-Wallace KM; Wilson BM; Bonomo RA Expert Opin Pharmacother; 2016; 17(6):761-81. PubMed ID: 26799840 [TBL] [Abstract][Full Text] [Related]
38. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital. Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813 [TBL] [Abstract][Full Text] [Related]
39. High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae among Children in Dar es Salaam, Tanzania. Tellevik MG; Blomberg B; Kommedal Ø; Maselle SY; Langeland N; Moyo SJ PLoS One; 2016; 11(12):e0168024. PubMed ID: 27936054 [TBL] [Abstract][Full Text] [Related]